Evidence map›Paper›PMID 24811962›Full record

ArticleOphthalmology2014

Whole exome sequencing identifies CRB1 defect in an unusual maculopathy phenotype.

Stephen H Tsang, Tomas Burke, Maris Oll, Suzanne Yzer, Winston Lee, Yajing Angela Xie, Rando Allikmets

Open access · greenAbstract read
In one paragraph

Article in Ophthalmology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 69 citations in OpenAlex.

  1. Review
  2. Novel Genotype-Phenotype Correlations inOphthalmology science · 2026
    Article
  3. Article
  4. Article
  5. Characterization and AAV-mediatedMolecular therapy. Methods & clinical development · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. International journal of molecular sciences · 2021
    Observational
  14. Article
  15. Article
  16. CRB1 maculopathy presenting as fenestrated sheen macular dystrophy with 15-year follow-up.Documenta ophthalmologica. Advances in ophthalmology · 2021
    Article
  17. Review
  18. Article
  19. AAV-Molecular therapy. Methods & clinical development · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 4 countries.

Stephen H TsangDepartment of Ophthalmology, Columbia University, New York, New York; Department of Pathology & Cell Biology, Columbia University, New York, New York.
Tomas BurkeDepartment of Ophthalmology, Columbia University, New York, New York; Department of Ophthalmology, Stoke Mandeville Hospital, Aylesbury, Buckinghamshire, United Kingdom.
Maris OllDepartment of Ophthalmology, Columbia University, New York, New York; University Eye Clinic, Tartu University, Tartu, Estonia.
Suzanne YzerDepartment of Ophthalmology, Columbia University, New York, New York; Rotterdam Eye Hospital, Rotterdam, The Netherlands.
Winston LeeDepartment of Ophthalmology, Columbia University, New York, New York.
Yajing Angela XieDepartment of Ophthalmology, Columbia University, New York, New York.
Rando AllikmetsDepartment of Ophthalmology, Columbia University, New York, New York; Department of Pathology & Cell Biology, Columbia University, New York, New York. Electronic address: rla22@columbia.edu.
Columbia University · USRotterdam Eye Hospital · NLTartu University Hospital · EE

Funding

Instrumentation, Fabrication, and Design CoreP30EY019007 · NEI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Xin Zhang · 2010 to 2026
$12.9M
Therapeutic approaches for ABCA4-associated disordersR24EY019861 · NEI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI ALLIKMETS, RANDO L · 2011 to 2015
$7.2M
Toward mechanism- and gene-based therapies for retinal degenerationR01EY018213 · NEI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Stephen H Tsang · 2008 to 2026
$6.6M
Vision Sciences Training GrantT32EY013933 · NEI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Carol A. Mason, CAROL M TROY · 2001 to 2026
$5.3M
Completing genetic analysis of the ABCA4 locusR01EY021163 · NEI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI ALLIKMETS, RANDO L · 2011 to 2014
$2.4M
NEI NIH HHS EY018213NEI NIH HHS EY019007NEI NIH HHS EY019861NEI NIH HHS EY021163NEI NIH HHS P30 EY019007NEI NIH HHS R01 EY018213NEI NIH HHS R01 EY021163NEI NIH HHS R24 EY019861NEI NIH HHS T32 EY013933
6 · The paper itself

Abstract

objectiveTo report a new phenotype caused by mutations in the CRB1 gene in a family with 2 affected siblings.

designMolecular genetics and observational case studies.

participantsTwo affected siblings and 3 unaffected family members.

methodsEach subject received a complete ophthalmic examination together with color fundus photography, fundus autofluorescence (FAF), and spectral-domain optical coherence tomography (SD-OCT). Microperimetry 1 (MP-1) mapping and electroretinogram (ERG) analysis were performed on the proband. Screening for disease-causing mutations was performed by whole exome sequencing in 3 family members followed by segregation analyses in the entire family.

main outcome measuresAppearance of the macula as examined by clinical examination, fundus photography, FAF imaging, SD-OCT, and visual function by MP-1 and ERG.

resultsThe proband and her affected brother exhibited unusual, previously unreported, findings of a macular dystrophy with relative sparing of the retinal periphery beyond the vascular arcades. The FAF imaging showed severely affected areas of hypoautofluorescence that extended nasally beyond the optic disc in both eyes. A central macular patch of retinal pigment epithelium (RPE) sparing was evident in both eyes on FAF, whereas photoreceptor sparing was documented in the right eye only using SD-OCT. The affected brother presented with irregular patterns of autofluorescence in both eyes characterized by concentric rings of alternating hyper- and hypoautofluorescence, and foveal sparing of photoreceptors and RPE, as seen on SD-OCT, bilaterally. After negative results in screening for mutations in candidate genes including ABCA4 and PRPH2, DNA from 3 members of the family, including both affected siblings and their mother, was screened by whole exome sequencing resulting in identification of 2 CRB1 missense mutations, c.C3991T:p.R1331C and c.C4142T:p.P1381L, which segregated with the disease in the family. Of the 2, the p.R1331C CRB1 mutation has not been described before and the p.P1381L variant has been described in 1 patient with Leber congenital amaurosis.

conclusionsThis report illustrates a novel presentation of a macular dystrophy caused by CRB1 mutations. Both affected siblings exhibited a relatively well-developed retinal structure and preservation of generalized retinal function. An unusual 5-year progression of macular atrophy alone was observed that has not been described in any other CRB1-associated phenotypes.

Indexed as

AdultDNA Mutational AnalysisEye ProteinsFemaleHumansMacular DegenerationMaleMembrane ProteinsMiddle AgedMutation, MissenseNerve Tissue ProteinsPhenotypeSequence Analysis, DNASiblingsCRB1 protein, humanEye ProteinsMembrane ProteinsNerve Tissue Proteins

Identifiers

PMID24811962
PMCPMC4145015
OpenAlexW2098871588

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.